Combined modality therapy for NSCLC: Perils and promise Published 2013-12-30 Download video MP4 360p Download video MP4 720p Recommendations 59:27 Siddhartha Mukherjee | The Song of the Cell: An Exploration of Medicine and the New Human 15:42 Screen discovered nodules: What next? 27:43 Treating Non-Muscle Invasive Bladder Cancer - Bivalacqua - DC 02:37 CBT Treatment Goals for Schizophrenia 1:02:12 Living with Neuroendocrine Cancer, newly diagnosed 13:50 4 Tricks for when doctors gaslight you - Dr. Kaveh LIVE 41:00 Dimko Zhluktenko - Tech Entrepreneurs are Helping Accelerate the Military Tech Revolution in Ukraine 45:06 EFN Direkt och Börslunch 12 juni 11:30 44:03 EGFR: The Challenge of Primary and Secondary Resistance 59:12 Rethinking ADHD - Dr Russell Ramsay 42:08 Pulmonary Hypertension: A challenging cause of shortness of breath 31:06 3 BIGGEST MISTAKES MADE WHEN DIAGNOSED WITH CANCER!-with Dr. Christy Kesslering and Dr. Eric Westman 19:58 When and how to intervene on the growing pulmonary nodule 05:32 Introduction to EGFR inhibitors 1:24:30 A Journey Through the Psychedelic Revival: What Happens in Psychedelic Therapy? 1:01:24 The Endocannabinoid System and Cannabis Pharmacology with Dr. Mike Butler 18:40 Matthew Perry's death from Ketamine explained (is it safe for you?) 47:22 Dr. Josep Dalmau speaker at "Autoimmune Encephalitis: The Bridge Between Neurology and Psychiatry" 21:33 3 things you NEED to ask your doctor before surgery 13:05 Kirsty's Story Similar videos 21:16 Locally advanced NSCLC: Choice and sequencing of systemic agents in combined modality therapy 25:26 Locally advanced NSCLC: Combination therapy with targeted and immunotherapy agents 44:30 Winship Grand Rounds March 30, 2016: Feng Ming Spring Kong, MD, PhD 23:42 Current Status of Adjuvant Therapy for NSCLC 41:05 Dr. Patrick Forde on Practical Benefits & Clinical Promise of Neoadjuvant Therapy in NSCLC | BTJ-022 36:55 Immunotherapy in Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team 05:15 Integrating Perioperative Immunotherapy Strategies in NSCLC 22:25 Surgical dilemmas in the management of locally advanced NSCLC 1:18:11 Management of EGFR-Mutant Lung Cancer With Central Nervous System Metastases 1:11:16 Immunotherapy as a Game-Changer in Multimodal Management of Lung Cancer 1:08:14 Advances in Diagnosis and Treatment of Lung Cancer 1:09:51 Lung Cancer Biomarkers & Targeted Therapies - Webinar 1:08:00 Has Immunotherapy Brought Us to an Inflection Point in the Management of Stage I-III NSCLC? 20:48 Expert Perspectives: Thoracic Malignancies 29:32 Controversies in Barrett’s Esophagus | V. Raman Muthusamy, MD | UCLA Digestive Disease 1:57:54 abc Oncology Course 2020 - Lung Cancer Module- Session I 1:19:57 Together Facing Lung Cancer 2022 1:10:20 Watch Drs Broderick & Wakelee discuss the latest in NSCLC: https://bit.ly/2021-NSCLC More results